PROSTATE CANCER: Mapping the course after CHAARTED

    loading  Checking for direct PDF access through Ovid

Abstract

The results of the phase III CHAARTED trial investigating androgen deprivation therapy (ADT) plus docetaxel for men with metastatic hormone-sensitive prostate cancer challenge the long-established standard of care of ADT alone for these men. The next step will be to integrate these results into clinical practice.

Related Topics

    loading  Loading Related Articles